NSIM
TNXP icon

North Star Investment Management’s Tonix Pharmaceuticals TNXP Stock Holding History

North Star Investment Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$664 Hold
52
– – ﹤0.01% 1604
2026
Q1 		$715 Hold
52
– – ﹤0.01% 1541
2025
Q4 		$812 Hold
52
– – ﹤0.01% 1416
2025
Q3 		$1.26K Hold
52
– – ﹤0.01% 1154
2025
Q2 		$1.87K Hold
52
– – ﹤0.01% 1096
2025
Q1 		$930 Sell
52
-1
-2% -$20 ﹤0.01% 1125
2024
Q4 		$1.74K Buy
+53
New +$1.1K ﹤0.01% 1126
2024
Q2 		– Hold
0
– -$1 – 1236
2024
Q1 		– Hold
0
– – – 1236
2023
Q4 		– Hold
0
– – – 1188
2023
Q3 		– Hold
0
– – – 1277
2023
Q2 		– Hold
0
– – – 1289
2023
Q1 		– Hold
0
– – – 1298
2022
Q4 		– Hold
0
– – – 1311
2022
Q3 		– Hold
0
– – – 1182
2022
Q2 		– Hold
0
– – – 1182
2022
Q1 		– Hold
0
– – – 1211
2021
Q4 		– Hold
0
– – – 1214
2021
Q3 		– Hold
0
– – – 1101
2021
Q2 		– Hold
0
– – – 1073
2021
Q1 		– Hold
0
– – – 1032
2020
Q4 		– Hold
0
– – – 1061

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

North Star Investment Management's TNXP Position: Q2 2026 in Review

North Star Investment Management held its Tonix Pharmaceuticals (TNXP) position steady in Q2 2026 at 52 shares worth $664. The position accounts for ﹤0.01% of the portfolio, ranked #1604.

North Star Investment Management first reported a position in TNXP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.87K in Q2 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • North Star Investment Management held 52 shares of Tonix Pharmaceuticals worth $664 as of Q2 2026.
  • North Star Investment Management left its Tonix Pharmaceuticals share count unchanged in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of North Star Investment Management's portfolio in Q2 2026, its #1604 holding.
  • North Star Investment Management first reported a position in Tonix Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • North Star Investment Management's Tonix Pharmaceuticals position peaked at $1.87K in Q2 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on North Star Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.